George S Alexopoulos1, Martha L Bruce. 1. Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College, 21 Bloomingdale Road, White Plains, NY, USA. gsalexop@med.cornell.edu
Abstract
OBJECTIVE: To serve as a conceptual map of the role of new interventions designed to reduce the burden of late-life depression. METHODS: We identified three needs to be addressed by intervention research: (1) the need for novel interventions given that the existing treatments leave many older adults depressed and disabled; (2) the need for procedures enabling community-based agencies to offer interventions of known efficacy with fidelity; and (3) the need to increase access of depressed older adults to care. RESULTS: Our model orders novel interventions according to their role in serving depressed older adults and according to their position in the efficacy, effectiveness, implementation, and dissemination testing continuum. We describe three interventions designed by our institute to exemplify intervention research at different level of the model. A common element is that each intervention personalizes care both at the level of the individuals served and the level of community agencies providing care. To this end, each intervention is designed to accommodate the strengths and limitations of both patients and agencies and introduces changes in the patients' environment and community agencies needed in order to assimilate the new intervention. CONCLUSIONS: We suggest that this model provides conceptual guidance on how to shorten the testing cycle and bring urgently needed novel treatments and implementation approaches to the community. While replication studies are important, propose that most of the support should be directed to those projects that take rational risks, and after adequate preliminary evidence, make the next step along the testing continuum. Copyright (c) 2009 John Wiley & Sons, Ltd.
OBJECTIVE: To serve as a conceptual map of the role of new interventions designed to reduce the burden of late-life depression. METHODS: We identified three needs to be addressed by intervention research: (1) the need for novel interventions given that the existing treatments leave many older adults depressed and disabled; (2) the need for procedures enabling community-based agencies to offer interventions of known efficacy with fidelity; and (3) the need to increase access of depressed older adults to care. RESULTS: Our model orders novel interventions according to their role in serving depressed older adults and according to their position in the efficacy, effectiveness, implementation, and dissemination testing continuum. We describe three interventions designed by our institute to exemplify intervention research at different level of the model. A common element is that each intervention personalizes care both at the level of the individuals served and the level of community agencies providing care. To this end, each intervention is designed to accommodate the strengths and limitations of both patients and agencies and introduces changes in the patients' environment and community agencies needed in order to assimilate the new intervention. CONCLUSIONS: We suggest that this model provides conceptual guidance on how to shorten the testing cycle and bring urgently needed novel treatments and implementation approaches to the community. While replication studies are important, propose that most of the support should be directed to those projects that take rational risks, and after adequate preliminary evidence, make the next step along the testing continuum. Copyright (c) 2009 John Wiley & Sons, Ltd.
Authors: Gwenn S Smith; Elisse Kramer; Carol R Hermann; Sara Goldberg; Yilong Ma; Vijay Dhawan; Anna Barnes; Thomas Chaly; Abdel Belakhleff; Fouzia Laghrissi-Thode; Blaine Greenwald; David Eidelberg; Bruce G Pollock Journal: Am J Geriatr Psychiatry Date: 2002 Nov-Dec Impact factor: 4.105
Authors: R O'Hara; C M Schröder; R Mahadevan; A F Schatzberg; S Lindley; S Fox; M Weiner; H C Kraemer; A Noda; X Lin; H L Gray; J F Hallmayer Journal: Mol Psychiatry Date: 2007-03-13 Impact factor: 15.992
Authors: Laura N Gitlin; Lynn Fields Harris; Megan C McCoy; Nancy L Chernett; Laura T Pizzi; Eric Jutkowitz; Edward Hess; Walter W Hauck Journal: Ann Intern Med Date: 2013-08-20 Impact factor: 25.391
Authors: Adam Simning; Thomas M Richardson; Bruce Friedman; Lisa L Boyle; Carol Podgorski; Yeates Conwell Journal: Int Psychogeriatr Date: 2010-05-18 Impact factor: 3.878
Authors: Martha L Bruce; Stephen J Bartels; Jeffrey M Lyness; Jo Anne Sirey; Yvette I Sheline; Gwenn Smith Journal: Acad Med Date: 2011-09 Impact factor: 6.893
Authors: Mario Ulises Pérez-Zepeda; Victoria Eugenia Arango-Lopera; Fernando A Wagner; Joseph J Gallo; Sergio Sánchez-García; Teresa Juárez-Cedillo; Carmen García-Peña Journal: Int J Geriatr Psychiatry Date: 2013-04-14 Impact factor: 3.485